Institute of Tropical Pathology and Public Health, Federal University of Goiás (UFG), Goiás, Brazil.
State University of Piauí, Piauí, Brazil.
J Med Virol. 2018 Oct;90(10):1651-1657. doi: 10.1002/jmv.25231. Epub 2018 Jun 7.
Independent epidemiology for respective human T-cell lymphotropic virus (HTLV) types 1 and 2 is little known in blood donors in Brazil, where screening for HTLV-1/2 is mandatory at blood banks, but no testing to confirm/differentiate these viruses. Therefore, this study aims to assess the prevalence of HTLV-1 and -2 in a first-time blood donor population in Northeastern Brazil and to carry out molecular characterization of respective isolates. A cross-sectional study was conducted at the State Blood Bank in Piauí. Samples were screened for anti-HTLV-1/2 by enzyme immunoassay, and reactive samples were confirmed using a line immunoassay and polymerase chain reaction (PCR). Of 37 306 blood donors, 47 were anti-HTLV-1/2 reactive by enzyme immunoassay. After confirmed by line immunoassay, 22 were positive for HTLV-1 (0.59 per 1000; 95% CI: 0.38-0.87), 14 were positive for HTLV-2 (0.37 per 1000; 95% CI: 0.21-0.61), 1 was indeterminate, and the remaining donors were negative. The HTLV-1 infection was also confirmed by PCR in all anti-HTLV-1-positive samples, and sequencing classified these isolates as belonging to the Transcontinental (A) subgroup of the Cosmopolitan (1a) subtype. Of 14 anti-HTLV-2-positive samples, 11 were also PCR positive, which belonged to subtype a (HTLV-2a/c). In addition, 38 family members of 5 HTLV-1- and 3 HTLV-2-infected donors were analyzed. Familial transmission of HTLV-1 and -2 was evidenced in 3 families. In conclusion, in Northeastern Brazil, where HTLV-1 and -2 are endemic, counseling blood donor candidates and their families might play a key role in limiting the spread of these viruses.
巴西的血液中心对 HTLV-1/2 进行强制性筛查,但没有检测来确认/区分这些病毒,因此,在巴西东北部的首次献血人群中,人们对各自的 HTLV-1 和 -2 型病毒的独立流行病学情况知之甚少。本研究旨在评估巴西东北部首次献血人群中 HTLV-1 和 -2 的流行率,并对各自的分离株进行分子特征分析。本研究采用横断面研究方法,在皮奥伊州州立血库进行。采用酶联免疫吸附试验(EIA)筛查抗 HTLV-1/2,采用免疫印迹试验(WB)和聚合酶链反应(PCR)确认反应性样本。在 37306 名献血者中,有 47 名通过 EIA 呈抗 HTLV-1/2 反应。经 WB 确认后,有 22 名 HTLV-1 阳性(每 1000 人中有 0.59 例;95%CI:0.38-0.87),14 名 HTLV-2 阳性(每 1000 人中有 0.37 例;95%CI:0.21-0.61),1 例为不确定,其余供者均为阴性。所有抗 HTLV-1 阳性样本均通过 PCR 确认 HTLV-1 感染,测序将这些分离株分类为泛大陆(A)亚群的世界型(1a)亚型。在 14 名抗 HTLV-2 阳性样本中,有 11 名也通过 PCR 检测呈阳性,属于 HTLV-2a/c 亚型。此外,还对 5 名 HTLV-1 感染者和 3 名 HTLV-2 感染者的 38 名家属进行了分析。有 3 个家庭证实存在 HTLV-1 和 -2 的家族传播。综上所述,在 HTLV-1 和 -2 流行的巴西东北部,对献血者候选人和其家属进行咨询可能对限制这些病毒的传播起到关键作用。